William Hinshaw insider trades: Axcella Health (AXLA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where William reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 19, 2022 | AXLA | ↓ Sell | 16,000 | $1.56 | $25K | Direct | Oct 19, 2022 (0d) |
| Mar 16, 2022 | AXLA | ↑ Buy | 13,089 | $1.91 | $25K | Direct | Mar 18, 2022 (2d) |
| Jan 31, 2022 | AXLA | ↓ Sell | 16,590 | $1.65 | $27K | Direct | Feb 1, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About William Hinshaw's insider trades
William Hinshaw is President & CEO at Axcella Health (AXLA). Since Jan 31, 2022, William has reported 1 open-market purchase worth $25K and 2 sales worth $52K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AXLA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.